FDA
approval
· 2018-02-01
FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
The FDA approved Amneal's supplemental application for buprenorphine HCl and naloxone HCl (buprenorphine and naloxone) under ANDA203136. The product is indicate…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE HCL AND NALOXONE HCL (BUPRENORPHINE AND NALOXONE)